Published in Biomed Res Int on July 14, 2013
Diagnosis and management of microscopic colitis: current perspectives. Clin Exp Gastroenterol (2014) 1.15
Towards a new paradigm of microscopic colitis: Incomplete and variant forms. World J Gastroenterol (2016) 0.75
Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology (2002) 5.50
Natalizumab for the treatment of active Crohn's disease: results of the ENCORE Trial. Gastroenterology (2007) 3.32
T cell homeostasis in patients with rheumatoid arthritis. Proc Natl Acad Sci U S A (2000) 3.06
Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms. Am J Gastroenterol (2009) 2.57
Collagenous colitis and fecal stream diversion. Gastroenterology (1995) 2.32
T-cell receptor alpha locus V(D)J recombination by-products are abundant in thymocytes and mature T cells. Mol Cell Biol (1996) 1.91
T cell receptor excision circles as markers for recent thymic emigrants: basic aspects, technical approach, and guidelines for interpretation. J Mol Med (Berl) (2001) 1.86
Review article: drug-induced microscopic colitis - proposal for a scoring system and review of the literature. Aliment Pharmacol Ther (2005) 1.77
Microscopic colitis. Gastroenterology (2011) 1.66
Dysregulated lymphocyte proliferation and differentiation in patients with rheumatoid arthritis. Blood (2002) 1.57
Microscopic colitis: Current status, present and future challenges: statements of the European Microscopic Colitis Group. J Crohns Colitis (2012) 1.56
20 years of gene therapy for SCID. Nat Immunol (2010) 1.33
Thymic export function and T cell homeostasis in patients with relapsing remitting multiple sclerosis. J Immunol (2003) 1.29
Diagnosis and management of microscopic colitis. World J Gastroenterol (2008) 1.24
Microscopic colitis patients demonstrate a mixed Th17/Tc17 and Th1/Tc1 mucosal cytokine profile. Mol Immunol (2013) 1.02
Microscopic colitis demonstrates a T helper cell type 1 mucosal cytokine profile. J Clin Pathol (2006) 1.01
T-cell receptor excision circles in primary immunodeficiencies and other T-cell immune disorders. Curr Opin Allergy Clin Immunol (2011) 1.00
Human T cell leukemias with continuous V(D)J recombinase activity for TCR-delta gene deletion. J Immunol (1997) 0.97
Yersinia species in collagenous colitis: a serologic study. Scand J Gastroenterol (2002) 0.94
Antiretroviral therapy corrects HIV-1-induced expansion of CD8+ CD45RA+ CD2-) CD11a(bright) activated T cells. J Allergy Clin Immunol (2008) 0.91
Cellular and molecular basis of intestinal barrier dysfunction in the irritable bowel syndrome. Gut Liver (2012) 0.89
Microscopic colitis patients have increased proportions of Ki67(+) proliferating and CD45RO(+) active/memory CD8(+) and CD4(+)8(+) mucosal T cells. J Crohns Colitis (2012) 0.89
Immunohistochemical characterization of lymphocytes in microscopic colitis. J Crohns Colitis (2013) 0.86
Dextran sulfate sodium-induced colitis generates a transient thymic involution--impact on thymocyte subsets. Scand J Immunol (2007) 0.86
Aberrant T-cell ontogeny and defective thymocyte and colonic T-cell chemotactic migration in colitis-prone Galphai2-deficient mice. Immunology (2007) 0.85
Rapid migration of thymic emigrants to the colonic mucosa in ulcerative colitis patients. Clin Exp Immunol (2010) 0.84
Thymectomy in ulcerative colitis: a report of cases over a 13 year period. Thymus (1991) 0.84
Increased transmucosal uptake of E. coli K12 in collagenous colitis persists after budesonide treatment. Am J Gastroenterol (2009) 0.83
DNA methylation profiles in monozygotic and dizygotic twins. Nat Genet (2009) 5.99
CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet (2002) 5.31
A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology (2010) 5.29
Shotgun metaproteomics of the human distal gut microbiota. ISME J (2008) 3.43
Resequencing of positional candidates identifies low frequency IL23R coding variants protecting against inflammatory bowel disease. Nat Genet (2010) 3.22
Molecular analysis of the gut microbiota of identical twins with Crohn's disease. ISME J (2008) 2.96
Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn's disease. Inflamm Bowel Dis (2009) 2.85
Appendectomy is followed by increased risk of Crohn's disease. Gastroenterology (2003) 2.62
Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics. Gastroenterology (2003) 2.57
Metabolomics reveals metabolic biomarkers of Crohn's disease. PLoS One (2009) 2.35
Geographical variability and environmental risk factors in inflammatory bowel disease. Gut (2013) 1.84
Integrated metagenomics/metaproteomics reveals human host-microbiota signatures of Crohn's disease. PLoS One (2012) 1.84
Environmental factors in inflammatory bowel disease: a co-twin control study of a Swedish-Danish twin population. Inflamm Bowel Dis (2006) 1.73
Combined polymorphisms in genes encoding the inflammasome components NALP3 and CARD8 confer susceptibility to Crohn's disease in Swedish men. Am J Gastroenterol (2009) 1.26
Diagnosis and management of microscopic colitis. World J Gastroenterol (2008) 1.24
Granulocyte, monocyte/macrophage apheresis for inflammatory bowel disease: the first 100 patients treated in Scandinavia. Scand J Gastroenterol (2007) 1.14
The Short Health Scale: a valid measure of subjective health in ulcerative colitis. Scand J Gastroenterol (2006) 1.10
Defining clinical criteria for clinical remission and disease activity in collagenous colitis. Inflamm Bowel Dis (2009) 1.05
Colonic mucosal tears in collagenous colitis. Scand J Gastroenterol (2006) 1.02
Microscopic colitis patients demonstrate a mixed Th17/Tc17 and Th1/Tc1 mucosal cytokine profile. Mol Immunol (2013) 1.02
Worries and concerns in a large unselected cohort of patients with Crohn's disease. Scand J Gastroenterol (2010) 1.01
Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid-refractory ulcerative colitis: a retrospective observational study. Inflamm Bowel Dis (2011) 1.00
Is smoking a risk factor for collagenous colitis? Scand J Gastroenterol (2011) 0.99
Short health scale: a valid, reliable, and responsive instrument for subjective health assessment in Crohn's disease. Inflamm Bowel Dis (2008) 0.96
Stable incidence of collagenous colitis and lymphocytic colitis in Örebro, Sweden, 1999-2008: a continuous epidemiologic study. Inflamm Bowel Dis (2013) 0.94
The influence of demographic and disease-related factors on health-related quality of life in patients with ulcerative colitis. Eur J Gastroenterol Hepatol (2003) 0.94
Colonic perforation in collagenous colitis: an unusual complication. Eur J Gastroenterol Hepatol (2005) 0.92
Health-related quality of life is impaired in active collagenous colitis. Dig Liver Dis (2010) 0.90
Prevalence and trends in adult-type hypolactasia in different age cohorts in Central Sweden diagnosed by genotyping for the adult-type hypolactasia-linked LCT -13910C > T mutation. Scand J Gastroenterol (2007) 0.90
Microscopic colitis patients have increased proportions of Ki67(+) proliferating and CD45RO(+) active/memory CD8(+) and CD4(+)8(+) mucosal T cells. J Crohns Colitis (2012) 0.89
Dendritic cells express CCR7 and migrate in response to CCL19 (MIP-3beta) after exposure to Helicobacter pylori. Microbes Infect (2006) 0.88
Long-term treatment with anti-alpha 4 integrin antibodies aggravates colitis in G alpha i2-deficient mice. Eur J Immunol (2005) 0.87
Hepatotoxicity by bosentan in a patient with portopulmonary hypertension: a case-report and review of the literature. J Gastrointestin Liver Dis (2011) 0.87
Long-term colectomy rate after intensive intravenous corticosteroid therapy for ulcerative colitis prior to the immunosuppressive treatment era. Am J Gastroenterol (2006) 0.86
Celiac disease and other autoimmune diseases in patients with collagenous colitis. Scand J Gastroenterol (2013) 0.86
Aberrant T-cell ontogeny and defective thymocyte and colonic T-cell chemotactic migration in colitis-prone Galphai2-deficient mice. Immunology (2007) 0.85
Clustering of Crohn's disease within affected sibships. Eur J Hum Genet (2003) 0.85
Unfavourable outcome for women in a study of health-related quality of life, social factors and work disability in Crohn's disease. Eur J Gastroenterol Hepatol (2011) 0.85
Subclinical inflammation with increased neutrophil activity in healthy twin siblings reflect environmental influence in the pathogenesis of inflammatory bowel disease. Inflamm Bowel Dis (2013) 0.83
IL-1 receptor-associated kinase M downregulates DSS-induced colitis. Inflamm Bowel Dis (2010) 0.83
Impaired activation of IFN-gamma+CD4+ T cells in peripheral blood of patients with dilated cardiomyopathy. Cell Immunol (2010) 0.81
A Pooled Analysis of Efficacy, Safety, and Long-term Outcome of Endoscopic Balloon Dilation Therapy for Patients with Stricturing Crohn's Disease. Inflamm Bowel Dis (2017) 0.81
Evaluation of the Inflammatory Bowel Disease Questionnaire in Swedish patients with Crohn's disease. Scand J Gastroenterol (2006) 0.80
Lack of effect of methotrexate in budesonide-refractory collagenous colitis. Clin Exp Gastroenterol (2013) 0.79
Longitudinal concordance for clinical characteristics in a Swedish-Danish twin population with inflammatory bowel disease. Inflamm Bowel Dis (2007) 0.79
CD4+FoxP3+ regulatory T cells from Gαi2-/- mice are functionally active in vitro, but do not prevent colitis. PLoS One (2011) 0.78
Interplay between T(h)1 and T(h)17 effector T-cell pathways in the pathogenesis of spontaneous colitis and colon cancer in the Gαi2-deficient mouse. Int Immunol (2012) 0.78
Factors predicting the outcome of disease activity assessment in Crohn's disease. Inflamm Bowel Dis (2009) 0.78
Effect of fasting on diarrhoea in collagenous colitis. Digestion (2002) 0.78
Analysis of single nucleotide polymorphisms in the region of CLDN2-MORC4 in relation to inflammatory bowel disease. World J Gastroenterol (2013) 0.77
Use of complementary and alternative medicine in Swedish patients with inflammatory bowel disease: a controlled study. Eur J Gastroenterol Hepatol (2016) 0.77
Increased prevalence of antibodies against dietary proteins in children and young adults with cerebral palsy. J Pediatr Gastroenterol Nutr (2013) 0.76
Polymorphism in the retinoic acid metabolizing enzyme CYP26B1 and the development of Crohn's Disease. PLoS One (2013) 0.75
Celiac disease and giardiasis: a case report. Eur J Gastroenterol Hepatol (2012) 0.75
Large intestine: Remission of lymphocytic colitis with budesonide. Nat Rev Gastroenterol Hepatol (2009) 0.75
Elution of antitransglutaminase antibodies from duodenal biopsies: a novel approach in the diagnosis of celiac disease. APMIS (2012) 0.75
Oligoclonal T-cell Receptor Repertoire in Colonic Biopsies of Patients with Microscopic Colitis and Ulcerative Colitis. Inflamm Bowel Dis (2017) 0.75
Family history, comorbidity, smoking and other risk factors in microscopic colitis: a case-control study. Eur J Gastroenterol Hepatol (2017) 0.75
Microscopic colitis: a common and an easily overlooked cause of chronic diarrhoea. Eur J Intern Med (2008) 0.75
[Microscopic colitis--more common cause of diarrhea than believed. Biopsies are the only way to diagnosis, drug treatment is effective]. Lakartidningen (2005) 0.75